Effect of desmopressin substitution during organ procurement on early renal allograft function

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 173-176

  Hirschl, M M ^a,b   Matzner, M P ^a   Huber, W O ^a   Binder, M ^b   Roggla G ^a   Derfler, K ^a   Muhlbacher F ^a   Laggner, A N ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Desmopressin; Diabetes insipidus; Organ donor; Renal allograft function

Indexed keywords

DESMOPRESSIN; NEUROHYPOPHYSIS HORMONE;

ADULT; AGED; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES INSIPIDUS; FEMALE; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT;

EID: 0030040339     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.1.173     Document Type: Article

References (15)

1. Soifer BE, Gelb AW. The multiple organ donor: identification and management. Ann Intern Med 1989; 110: 814-823
2. Bodenham A, Park GR. Care of the multiple organ donor. Intensive Care Med 1989; 15: 340-348
3. Kirchner E. Stabilisation of the cardiovascular system in organ donors. Anaesthesiol Reanimat 1989; 14: 83-88
4. Darby JM, Stein K, Grenvik A, Stuart S. Approach to management of the heartbeating "brain dead" organ donor. JAMA 1989; 261: 2222-2228
5. Hays RM. Agents affecting the renal conservation of water. In: Gilman AC, Goodman LS, Rall TW, Murad F, eds. Goodman and Gilman's Pharmacological Basis of Therapeutics. 6th edn. MacMillan, New York, 1985; 908-923
6. Schneider A, Toledo-Pereyra LH, Zeichner WD, Allaben R, Whitten J. Effect of dopamine and pitressin on kidneys procured and harvested for transplantation. Transplantation 1983; 36: 110-111
7. Debelak L, Pollak R, Reckard C. Arginine desmopressin versus desmopressin for the treatment of diabetes insipidus in the brain dead organ donor. Transplant Proc 1990; 22: 351-352
8. Whelchel JD, Diethelm AG, Phillips MG, Rhyder WR, Schein LG. The effect of high-dose dopamine in cadaver donor management on delayed graft function and graft survival following renal transplantation. Transplant Proc 1986; 18: 523-527
9. Heidbreder E, Zollner T, Schafferhans K, Götz R. Atrial natriuretic peptide reverses experimental acute renal failure induced by arginine desmopressin. Miner Electrolyte Metab 1990; 16: 48-53
10. Hohenegger M, Vermes M, Mauritz W, Redl G, Sporn P, Eiseisberg P. Serum desmopressin (AVP) levels in polyuric brain-dead organ donors. Eur Arch Psychiatr Neurol Sci 1990; 239: 267-269
11. Koller J, Wieser C, Kornberger R et al. Influence of the renin-angiotensin system of the organ donor on kidney function after transplantation. Transplant Proc 1990; 22: 349-350
12. Wetzels JFM, Hoitsma AJ, Koene RAP. Influence of cadaver donor age on renal graft survival. Clin Nephrol 1986; 25: 256-259
13. Neumayer HH, Eis M, Link J, Mühlberg J, Wagner K. Factors influencing primary kidney graft function. Transplant Proc 1986; 18: 506-509
14. Ontario Renal Transplant Research Group. Factors contributing to primary nonfunction of cadaver kidney transplants. Transplant Proc 1986; 18: 516-518
15. Xiao X, Li V, Ao J, Chen Y. Analysis of prognostic factors affecting renal allograft survival. Transplant Int 1992; 5: 226-230